| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 07/28/2004 | CN1159445C Recombinant adevovirus for tissue specifie expression in heart |
| 07/28/2004 | CN1159057C Medicine for treating hepatitis, and preparing process thereof |
| 07/28/2004 | CN1159053C Compoiste bear gall spray for treating rhinocleisis and its preparing process |
| 07/28/2004 | CN1159050C Composite chinese medicine preparation for treating type II diabetes |
| 07/28/2004 | CN1159040C Chinese medicine for curing gastropathy and its preparation method |
| 07/28/2004 | CN1159039C Capsule, oral liquid and face mask with health care function |
| 07/28/2004 | CN1159037C Medicine for treating apoplexy |
| 07/28/2004 | CN1159036C Eye drops |
| 07/28/2004 | CN1159033C Chinese medicine composition for gynopathy |
| 07/28/2004 | CN1159032C Exterior-applied plaster for treating lumber vertebra disease, cervical vertebra disease and osteoarthropathy and ite preparing process |
| 07/28/2004 | CN1159031C Tonglinxiaozheng particles for treating carcinoma of urinary bladder and its preparing process |
| 07/28/2004 | CN1159030C Capsule for curing varicosis and its preparing method |
| 07/28/2004 | CN1159026C Medicine for treating tumor and its preparing process |
| 07/28/2004 | CN1159025C Chinese medicine for optimally taking care of brain health |
| 07/28/2004 | CN1159023C Jiangu Capsule for strengthening bone |
| 07/28/2004 | CN1159020C Production method of gastric ulcer quickly-healing prepartion |
| 07/28/2004 | CN1159018C Honey Preparation to treat hand dermatitis caused by silk reeling |
| 07/27/2004 | US6767990 Peptides used as angiotensin converting enzyme inhibitor and preparation process thereof |
| 07/27/2004 | US6767740 Stem cell and dental pulp harvesting method and apparatus |
| 07/27/2004 | US6767738 Repairing damaged or diseased, specialized or differentiated tissue in mature animals, like neuronal tissue such as retinas transplantation of adult, hippocampus-derived progenitor cells into a selected neural tissue site of a recipient |
| 07/27/2004 | US6767737 Phenotype of stem cells which contain a fibroblast growth factor receptor (fgfr) on the cell surface thereof and further have a phenotype indicative of a primitive state |
| 07/27/2004 | US6767543 Inoculating a mycelial inoculum of an isolate of antrodia camphorata; subjecting culture cultivated to first stage of agitation to obtain second culture proliferation with mycelium; agitation to subject isolate to physiological stress |
| 07/27/2004 | US6767537 Composition and method for the treatment of sinusitis |
| 07/27/2004 | US6767533 Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress |
| 07/22/2004 | WO2004061115A1 PROCESS FOR PRODUCING SOLUBLE β-GLUCAN HAVING IMMUNOLOGICAL FUNCTION AND USE THEREOF |
| 07/22/2004 | WO2004061091A2 Insulin producing cells |
| 07/22/2004 | WO2004061090A1 Composition capable of activating natural killer cells and process for producing the same, composition containing natural killer cells activated by the former composition and process for producing the same |
| 07/22/2004 | WO2004061089A1 Dendritic cell line |
| 07/22/2004 | WO2004060381A1 Rabbit skin comprising biological active substance and its use |
| 07/22/2004 | WO2004060342A1 Nutritional supplement composition and method |
| 07/22/2004 | WO2004060303A2 Methods and reagents for the enhancement of virus transduction in the bladder epithelium |
| 07/22/2004 | WO2004026238A8 Immunotherapeutic compositions and methods for the treatment of moderately to well-differentiated cancers |
| 07/22/2004 | WO2004022079A8 Method for reinstalling control system for antigenic homeostasis of mammalian organisms (effect of kukharchuk-radchenko-sirman) |
| 07/22/2004 | WO2003106695A3 Methods and compositions for in vivo clearance of pathogens |
| 07/22/2004 | WO2003087303A3 Tissue composites and uses thereof |
| 07/22/2004 | WO2003075843A3 Multiple and multivalent dna vaccines in ovo |
| 07/22/2004 | WO2002101076A3 Methods for targeted expression of therapeutic nucleic acid |
| 07/22/2004 | US20040142901 Production of pancreatic islet cells and delivery of insulin |
| 07/22/2004 | US20040142886 use of vascular endothelial growth factor to enhance smooth muscle cell proliferation and to treat diseases associated with reduced smooth muscle cell proliferation |
| 07/22/2004 | US20040142885 host cell; gene therapy |
| 07/22/2004 | US20040142861 at least one genetically-engineered growth factor, at least one genetically-engineered antioxidant, at least one genetically-engineered extracellular matrix component |
| 07/22/2004 | US20040142468 Modulation of systemic immune responses by transplantation of hematopoietic stem cells transduced with genes encoding antigens and antigen presenting cell regulatory molecules |
| 07/22/2004 | US20040142465 Injectable hyaluronic acid derivative with pharmaceuticals/cells |
| 07/22/2004 | US20040142453 Mycobacterial proteins, microorganisms producing them and their use for vaccines and for the detection of tuberculosis |
| 07/22/2004 | US20040142448 Recovery of recombinant human parainfluenza virus type 1 (HPIV1) from cDNA and use of recombinant HPIV1 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens |
| 07/22/2004 | US20040142431 Nucleotide sequences comprising restriction fragment length polymorphisms coding polypeptide with antiproliferative, antiviral and antiparasitic effects |
| 07/22/2004 | US20040142002 Recombinant poxvirus |
| 07/22/2004 | US20040142000 Immune activator |
| 07/22/2004 | US20040141956 Method of preventing surgical adhesions |
| 07/22/2004 | US20040141954 composition comprising a daidzein-containing substance and a strain of microorganism capable of metabolizing daidzein to equol as essential ingredients |
| 07/22/2004 | CA2510903A1 Methods and reagents for the enhancement of virus transduction in the bladder epithelium |
| 07/21/2004 | EP1439190A1 Growth differentiation factor-5 |
| 07/21/2004 | EP1438968A1 Topical compositions containing at least one polypeptide hydrolase with an amidasic activity and /or compounds capable of modulating this activity |
| 07/21/2004 | EP1438964A1 Process for producing collagen production enhancers and use thereof |
| 07/21/2004 | EP1438431A2 Methods for diagnosing and treating heart disease |
| 07/21/2004 | EP1438418A2 Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| 07/21/2004 | EP1438412A2 Methods and compositions for inducing tumor-specific cytotoxicity |
| 07/21/2004 | EP1438410A2 Promoters to control cell differentiation |
| 07/21/2004 | EP1438395A1 Growing xenotransplant material in culture |
| 07/21/2004 | EP1438393A1 Differentiation of whole bone marrow |
| 07/21/2004 | EP1438392A2 Cell populations which co-express cd49c and cd90 |
| 07/21/2004 | EP1438390A2 Circadian control of stem/progenitor cell self-renewal and differentiation and of clock controlled gene expression |
| 07/21/2004 | EP1438088A2 Bag system for cryopreservation of body fluids |
| 07/21/2004 | EP1438075A2 Methods and compositions relating to restricted expression lentiviral vectors and their applications |
| 07/21/2004 | EP1438070A1 Treating vascular disease by inhibiting toll-like receptor-4 |
| 07/21/2004 | EP1404351A4 Carbohydrate modifying agent and drinks containing the modifying agent |
| 07/21/2004 | EP1268833B1 Modified nodavirus rna for gene delivery |
| 07/21/2004 | EP1232203B1 3d matrix for producing cell transplants |
| 07/21/2004 | EP1200110A4 In vivo induction for enhanced function of isolated hepatocytes |
| 07/21/2004 | EP0941329B1 Methods for preventing graft rejection in transplantation and for producing a universal gene therapy host cell using lymphocyte activation (lag-3) |
| 07/21/2004 | CN1514877A Method for autologous transplantation |
| 07/21/2004 | CN1514688A Oncolytic virus therapy |
| 07/21/2004 | CN1513984A Bifidus strain carrying plasmid pBIF10 and its application |
| 07/21/2004 | CN1513971A Medical health protection type deer bone (glue) wine |
| 07/21/2004 | CN1513850A Rhodoalkane kind compound, synthesis method and its use |
| 07/21/2004 | CN1513551A Compound biological preparation composition and its preparation method |
| 07/21/2004 | CN1513537A Medicine for treating hepatitis B and its preparation method |
| 07/21/2004 | CN1513482A Extraction of Malassezia for treating chlosma, said prepn. and its prepn. method and application thereof |
| 07/21/2004 | CN1513481A Method for preparing non-specific immunity activator |
| 07/21/2004 | CN1513480A Artificial bear gall |
| 07/21/2004 | CN1513479A Method for producing ointmen for treating hemorrhoids |
| 07/21/2004 | CN1513478A Oral Prepn. |
| 07/21/2004 | CN1513477A Method and device for removing impurties or sneaking into substance of raw medicine |
| 07/21/2004 | CN1158109C Biologically composite artificial bone and its preparing process |
| 07/21/2004 | CN1158105C Chinese medicine for making body stronger and delayinbg senility and its preparing process |
| 07/21/2004 | CN1158102C Chinese medicine for treating nocturnal fever |
| 07/21/2004 | CN1158101C Process for preparing medicine to treat hepatitis |
| 07/21/2004 | CN1158100C Medicine for nasal obstruction |
| 07/21/2004 | CN1158098C Lutai oral liquor |
| 07/21/2004 | CN1158097C Medicine for treating anal disease and its prepn |
| 07/21/2004 | CN1158096C Cancer and tumor treating capsule and its prepn |
| 07/21/2004 | CN1158095C Chinese medicine for treating rheumatoid arthritis |
| 07/21/2004 | CN1158093C Medicine composition containing yak bone for treating rhenmatism and method for making same |
| 07/21/2004 | CN1158091C Chinese medicine composition for treating lung cancer |
| 07/21/2004 | CN1158085C Fe-Ca nutrient composition and its preparation method |
| 07/20/2004 | US6764838 Use of parasitic biological agents for prevention and control of autoimmune diseases |
| 07/20/2004 | US6764688 Culturing human peripheral blood cells in device coated with anti-cd3 antibody and an f(ab)2 fragment of the anti- cd2 antibody ts2/18 produced from hybridoma hb-195 |
| 07/20/2004 | US6764687 Live attenuated bacteria for use in a vaccine |
| 07/20/2004 | US6764684 Avian herpesvirus-based recombinant infectious bursal disease vaccine |
| 07/20/2004 | US6764683 Stimulation of hematopoiesis in patients undergoing cytotoxic cancer chemotherapy; preventing mucositis; cytoprotection |